We synthesized two organometallic
diazepam-
palladium(II) derivatives by C-H activation of
diazepam (DZP) with
palladium salts, i.e.,
PdCl2 and
Pd(OAc)2 (OAc=
acetate). Both compounds obtained are air stable and were isolated in good yields. The
anticonvulsant potential of the complexes, labeled [(DZP)
PdCl]2 and [(DZP)PdOAc]2, was evaluated through two animal models:
pentylenetetrazole (PTZ)- and
picrotoxin (PTX)-induced convulsions. The organometallic DZP-
palladium(II) acetate complex, [(DZP)PdOAc]2, significantly increased (p<0.01 or p<0.001) latencies and protected the animals against convulsions induced by PTZ and PTX, while the analogous chloro derivative, [(DZP)
PdCl]2, was effective (p<0.01) only in the PTZ model. These effects appear to be mediated through the GABAergic system. The possible mechanism of action of the DZP-
palladium(II) complexes was also confirmed with the use of
flumazenil (FLU), a GABAA-
benzodiazepine receptor complex site antagonist. Herein, we present the first report of the
anticonvulsant properties of organometallic DZP-
palladium(II) complexes as well as evidence that these compounds may play an important role in the study of new drugs to treat patients with
epilepsy.